US · LFWD
Lifeward Ltd.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Yokneam Illit 2069203
- Website
- golifeward.com
Price · as of 2024-12-31
$7.25
Market cap 11.28M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $7.82 | +7.94% |
| Intrinsic Value(DCF) | $1,930.28 | +26,542.93% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | $4,095.00 | ||||
| 2017 | $2,467.50 | $15,749.06 | $0.00 | $0.00 | $0.00 |
| 2018 | $483.00 | $19,261.08 | $0.00 | $0.00 | $8,400.60 |
| 2019 | $55.36 | $97.49 | $0.00 | $0.00 | $3,708.77 |
| 2020 | $262.92 | $705.34 | $35.10 | $0.00 | $86.01 |
| 2021 | $84.84 | $155.18 | $125.21 | $45.06 | $0.00 |
| 2022 | $61.57 | $41.96 | $60.43 | $0.00 | $0.00 |
| 2023 | $60.90 | $42.07 | $58,178.38 | $0.00 | $0.00 |
| 2024 | $19.56 | $7.82 | $682,244.33 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Lifeward Ltd.'s (LFWD) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $7.82
- Current price
- $7.25
- AI upside
- +7.94%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1,930.28
+26,542.93% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| LFWD | Lifeward Ltd. | $7.25 | 11.28M | +8% | +26,543% | — | — | -0.49 | 0.75 | 0.55 | -0.32 | -1.71 | 1.25 | 32.01% | -76.19% | -112.78% | -88.56% | -118.09% | -61.79% | 0.05 | -152.76 | 2.08 | 1.27 | 0.24 | 2857.00% | 8524.00% | 468.00% | -153.36% | -2.12 | -131.16% | 0.00% | 0.00% | 0.00% | -0.41 | -0.37 | 0.32 | -12.27 |
| DHAI | DIH Holding US, Inc. | $0.00 | 5.23K | +1,170,700% | +87,500% | — | — | -903.76 | -211.15 | 124.73 | -1104.70 | — | -211.15 | 51.24% | -7.74% | -13.80% | 24.90% | 20.72% | -27.77% | -0.32 | -15.34 | 0.49 | 0.12 | -1.41 | -2412.00% | -250.00% | -19379.00% | -0.06% | -0.10 | 19.94% | 0.00% | 0.00% | 0.03% | -1614.12 | -1677.58 | 124.89 | 72.12 |
| IINN | Inspira Technologies Oxy … | $0.58 | 13.97M | — | — | — | — | -1.42 | 3.64 | — | -1121.82 | — | 3.64 | 0.00% | — | — | -219.74% | 7.39% | -127.19% | 0.58 | — | 2.02 | 1.71 | 234.68 | -9994.00% | — | -426.00% | -60.68% | -2.78 | -6254.43% | 0.00% | 0.00% | 0.00% | 1104.79 | -1.31 | — | -8.52 |
| INAB | IN8bio, Inc. | $1.70 | 7.88M | — | — | — | — | -13.04 | 27.41 | — | -14.50 | — | 27.41 | 0.00% | — | — | -154.44% | -359.44% | -111.38% | 0.35 | — | 4.08 | 3.61 | 0.23 | -4300.00% | — | 131.00% | -6.11% | -7.83 | -286.41% | 0.00% | 0.00% | 0.00% | -12.84 | -16.11 | — | 24.43 |
| LYRA | Lyra Therapeutics, Inc. | $1.01 | 1.79M | +2,414% | +280% | — | — | -6.69 | 53.92 | 407.49 | -10.27 | -49.59 | 53.92 | 100.00% | -6280.83% | -6090.94% | -184.99% | -1017.13% | -89.43% | 2.97 | — | 3.41 | 3.21 | 0.10 | 1349.00% | -154.00% | 1243.00% | -11.57% | -5.54 | -763.78% | 0.00% | 0.00% | 1.72% | -6.42 | -8.55 | 403.45 | -5.91 |
| PTHL | Pheton Holdings Ltd Class… | $0.36 | 5.23M | +20,678% | +219% | -37% | +178% | -44.29 | 4.73 | 65.28 | -39.57 | -20.83 | 4.73 | 85.04% | -171.80% | -147.48% | -20.35% | -297.84% | -15.84% | 0.04 | — | 12.40 | 12.01 | 10.02 | 21265.00% | -2870.00% | 111922.00% | -2.65% | -1.44 | -300.11% | 0.00% | 0.00% | 19.99% | -30.32 | -30.09 | 52.09 | 33.27 |
| RNAZ | TransCode Therapeutics, I… | $9.61 | 8.81M | — | — | — | — | -0.93 | -7.75 | — | -0.61 | — | -7.75 | 0.00% | — | — | 8866.96% | 369.89% | -268.85% | -0.02 | -584.07 | 2.56 | 2.10 | 0.36 | -9864.00% | — | -2624.00% | -85.33% | -4.81 | 315.50% | 0.00% | 0.00% | 22.07% | -0.63 | -0.74 | — | -17.50 |
| SBFM | Sunshine Biopharma, Inc. | $1.20 | 5.89M | +4,340% | +64,945,046% | — | — | -0.33 | 0.07 | 0.05 | 1.37 | — | 0.08 | 30.60% | -16.67% | -14.72% | -22.97% | -54.65% | -17.73% | 0.04 | -662.41 | 4.11 | 2.15 | 1.69 | -9792.00% | 4475.00% | 5530.00% | -885.54% | -1.98 | -146.04% | 0.00% | 0.00% | 187.20% | 1.21 | 0.48 | -0.20 | -1.74 |
| SINT | Sintx Technologies, Inc. | $2.89 | 7.97M | +19,466% | -54% | — | +21,505% | -0.22 | 0.63 | 1.98 | -0.30 | — | 0.64 | 34.91% | -1127.37% | -884.75% | -174.07% | -193.62% | -88.98% | 1.03 | -484.38 | 2.41 | 1.91 | -0.04 | -2178.00% | -5257.00% | -3628.00% | -378.55% | -4.36 | -128.63% | 0.00% | 0.00% | 40.16% | -0.21 | -0.31 | 2.32 | -46.07 |
| TNON | Tenon Medical, Inc. | $0.87 | 7.5M | +21,018% | +210,838% | — | — | -0.12 | 0.26 | 0.48 | 0.35 | — | 0.26 | 52.21% | -420.08% | -417.24% | -405.19% | -38777.46% | -168.93% | 0.07 | -404.88 | 4.39 | 3.96 | 0.47 | -8360.00% | 1192.00% | -1977.00% | -637.69% | -5.29 | -28349.30% | 0.00% | 0.00% | 350.78% | 0.33 | 0.45 | -1.38 | -13.04 |
| XAIR | Beyond Air, Inc. | $0.96 | 4.87M | +6,086% | +58% | — | — | -0.27 | 0.95 | 3.47 | -0.42 | — | 1.04 | -44.89% | -1202.08% | -1258.43% | -250.98% | -332.73% | -111.42% | 0.86 | -14.75 | 3.20 | 1.56 | -0.17 | -6210.00% | 21967.00% | -2859.00% | -342.82% | -7.64 | -329.47% | 0.00% | 0.00% | 0.00% | -0.40 | -0.40 | 4.76 | -17.17 |
About Lifeward Ltd.
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.
- CEO
- William Mark Grant
- Employees
- 80
- Beta
- 0.14
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1,930.28 ÷ $7.25) − 1 = +26,542.93% (DCF, example).